Mechanisms of Right Ventricular Adaptation in Patients With Heart Failure With Preserved Ejection Fraction (INTERACT-HFpEF)
Primary Purpose
Heart Failure, Diastolic
Status
Unknown status
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
conductance catheter measurement
Sponsored by
About this trial
This is an interventional diagnostic trial for Heart Failure, Diastolic focused on measuring HFpEF, pulmonary hypertension
Eligibility Criteria
Inclusion criteria:
Diagnosis of HFpEF as follows
- Heart failure NYHA II or NYHA III
- LVEF ≥ 50%
- HFA-PEFF score ≥ 5 OR HFA-PEFF score 2-4 with one of the following criteria:
- baseline PCWP ≥ 15 mm Hg OR PCWP increase ≥ 10 mm Hg with exercise (~20 Watt)
- stable medical therapy for last 4 weeks
Exclusion criteria:
- Significant coronary stenosis > 50% or valvular heart disease requiring intervention
- coronary or cardiac valvular intervention < 3 months
- uncontrolled rate of atrial fibrillation
- Severe chronic kidney disease (MDRD eGFR < 30 ml/min)
- Life expectancy < 12 months
- Contraindication to MRI or other planned investigations
Sites / Locations
- Goethe University HospitalRecruiting
- University Hospital Justus-Liebig UniversityRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
biventricular conductance catheter
Arm Description
patients with indication for invasive assessment receive right and left heart catheter and parallel biventricular conductance catheter at rest and stress
Outcomes
Primary Outcome Measures
delta Eed
RV stiffness measured by conductance catheter is reduced alreday in early HFpEF stages
delta RV volume
homeometric followed by teterometric adaptation with consecutive dilation of the RV occurs with disease progression from HFpEF-Non-PH ti ICC-PH_HFpEF to cpc-PH-HFpEFprogressive H, impacting position and motion of the septum with stress
Secondary Outcome Measures
correlation of delta RV longitudinal strain with Eed
RV longitudinal strain (related to RV EDV) is the best predictor of RV diastolic stiffness (Eed) in HFpEF-PH (correlation analysis)
delta transmural septal pressure
acute change of the transmural pressure gradients from rest to stress conditions, adversly impacts LV filling
Full Information
NCT ID
NCT04154657
First Posted
November 4, 2019
Last Updated
July 27, 2020
Sponsor
Johann Wolfgang Goethe University Hospital
Collaborators
University of Giessen
1. Study Identification
Unique Protocol Identification Number
NCT04154657
Brief Title
Mechanisms of Right Ventricular Adaptation in Patients With Heart Failure With Preserved Ejection Fraction
Acronym
INTERACT-HFpEF
Official Title
Disclosing Mechanisms of Right Ventricular Adaptation in Patients With Heart Failure With Preserved Ejection Fraction With and Without Pulmonary Hypertension - Insights From Invasive Hemodynamic and Imaging
Study Type
Interventional
2. Study Status
Record Verification Date
July 2020
Overall Recruitment Status
Unknown status
Study Start Date
February 15, 2020 (Actual)
Primary Completion Date
December 2021 (Anticipated)
Study Completion Date
June 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Johann Wolfgang Goethe University Hospital
Collaborators
University of Giessen
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Biventricular PV-loop studies and advanced imaging to assess left-to-right ventricular interaction in HFpEF: In a group of 30 HFpEF patients with clinical indication for LH/RH catheter investigation, we will perform biventricular PV loop assessment in combination with extensive imaging (MRI, echo) for in-depth analysis of left-to-right ventricular interaction in the different HFpEF categories, both under baseline and stress (volume challenge and exercise) conditions.
Detailed Description
The right ventricle is the main determinant of prognosis in pulmonary hypertension . The response of the right ventricle to the structural alterations and increasing afterload in the pulmonary circulation is a complex process. The interplay between neuroendocrine and paracrine signalling and increased afterload may lead to myocardial ischemia and inflammation, resulting in loss of myocytes, myocardial fibrosis and RV-arterial uncoupling. Pulmonary hypertension in the setting of heart failure with preserved ejection fraction (HFpEF-PH) is a frequent complication which is associated with impaired prognosis. HFpEF-PH is defined by a high mean pulmonary artery pressure (> 20 mm Hg), high left ventricular end-diastolic pressure (LVEDP > 15 mm Hg) and a normal systolic left ventricular function with impaired diastolic function. However, not all HFpEF patients develop pulmonary vascular remodelling with a high transpulmonary pressure gradient, and increased pulmonary vascular resistance leading to adverse right ventricular remodelling. Ageing, increased left atrial pressure and stiffness, mitral regurgitation, as well as features of metabolic syndrome, including obesity, diabetes and hypertension, are recognized as clinical risk factors for HFpEF-PH. A main and emerging question in that context is the interplay between the right and left ventricle in HFpEF-PH, and whether diastolic left ventricular failure is the driving force of the hemodynamic and right ventricular functional changes. Recent studies have shown that HFpEF-PH patients demonstrate haemodynamic limitations during exercise, including impaired recruitment of LV preload due to excessive right heart congestion and blunted RV systolic reserve compared to HFpEF without PH . However, up to now, no data exist about the mechanism of interplay between RV, LV and pulmonary haemodynamics in HFpEF and HFpEF-PH. Whereas in patients with HFpEF, PV loop analysis has demonstrated that increased end-diastolic pressure at rest is associated with higher end-diastolic stiffness, and a consistently upwards and leftwards shifted pressure volume relationship during exercise and volume challenge, Gortner et al suggest that reduced LV preload (measured by LV transmural pressure gradient) due to excessive RV congestion, is a major driver for reduced cardiac output in HFpEF-PH. However, preliminary own data in 21 patients with HFpEF demonstrate a more complex relationship with approximately one third of patients not showing an increase of (RV and LV ) end-diastolic pressure volume relation during exercise.
Thus, a simultaneous PV loop-catheterization of LV and RV, in addition to right heart catheter, would therefore provide an enormous gain of knowledge about the interaction of RV and LV and would contribute to a better understanding of the pathophysiology of HFpEF-PH and HFpEF.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Failure, Diastolic
Keywords
HFpEF, pulmonary hypertension
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
single cohort observational pathophysiologic study
Masking
None (Open Label)
Allocation
N/A
Enrollment
30 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
biventricular conductance catheter
Arm Type
Experimental
Arm Description
patients with indication for invasive assessment receive right and left heart catheter and parallel biventricular conductance catheter at rest and stress
Intervention Type
Procedure
Intervention Name(s)
conductance catheter measurement
Other Intervention Name(s)
pressure volume loop catheter measurement
Intervention Description
biventricular parallel conductance catheter measurement at rest and stress conditions, + CMR at rest and stress
Primary Outcome Measure Information:
Title
delta Eed
Description
RV stiffness measured by conductance catheter is reduced alreday in early HFpEF stages
Time Frame
immediate after procedure
Title
delta RV volume
Description
homeometric followed by teterometric adaptation with consecutive dilation of the RV occurs with disease progression from HFpEF-Non-PH ti ICC-PH_HFpEF to cpc-PH-HFpEFprogressive H, impacting position and motion of the septum with stress
Time Frame
immediate after procedure
Secondary Outcome Measure Information:
Title
correlation of delta RV longitudinal strain with Eed
Description
RV longitudinal strain (related to RV EDV) is the best predictor of RV diastolic stiffness (Eed) in HFpEF-PH (correlation analysis)
Time Frame
immediate after procedure
Title
delta transmural septal pressure
Description
acute change of the transmural pressure gradients from rest to stress conditions, adversly impacts LV filling
Time Frame
immediate after procedure
10. Eligibility
Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria:
Diagnosis of HFpEF as follows
Heart failure NYHA II or NYHA III
LVEF ≥ 50%
HFA-PEFF score ≥ 5 OR HFA-PEFF score 2-4 with one of the following criteria:
baseline PCWP ≥ 15 mm Hg OR PCWP increase ≥ 10 mm Hg with exercise (~20 Watt)
stable medical therapy for last 4 weeks
Exclusion criteria:
Significant coronary stenosis > 50% or valvular heart disease requiring intervention
coronary or cardiac valvular intervention < 3 months
uncontrolled rate of atrial fibrillation
Severe chronic kidney disease (MDRD eGFR < 30 ml/min)
Life expectancy < 12 months
Contraindication to MRI or other planned investigations
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Birgit Assmus, MD
Phone
+49641985
Ext
42637
Email
birgit.assmus@innere.med.uni-giessen.de
First Name & Middle Initial & Last Name or Official Title & Degree
Khodr Tello, MD
Phone
+49641985
Ext
56087
Email
khodr.tello@innere.med.uni-giessen.de
Facility Information:
Facility Name
Goethe University Hospital
City
Frankfurt
State/Province
Hessen
ZIP/Postal Code
60590
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Eike Nagel, MD
Phone
+49696301
Ext
84491
Email
eike.nagel@kgu.de
First Name & Middle Initial & Last Name & Degree
Valentina M Puntmann, MD
Phone
+49696301
Ext
84491
Email
valentina.puntmann@kgu.de
Facility Name
University Hospital Justus-Liebig University
City
Gießen
ZIP/Postal Code
35392
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Birgit Assmus, MD
Phone
+49 641 985
Ext
42637
Email
birgit.assmus@innere.med.uni-giessen.de
First Name & Middle Initial & Last Name & Degree
Khodr Tello, MD
Phone
+49 641 985
Ext
56087
Email
khodr.tello@innere.med.uni-giessen.de
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Mechanisms of Right Ventricular Adaptation in Patients With Heart Failure With Preserved Ejection Fraction
We'll reach out to this number within 24 hrs